OS GSO EN 14683:2020

Omani Standard   Current Edition
· Approved on 10 May 2020 ·

Medical face masks - Requirements and test methods

Hospital equipment
Including hospital beds, surgical tables, medical garments, medical gloves, containers for sharp disposal, etc.

OS GSO EN 14683:2020 Files

English 18 Pages
Current Edition Reference Language

OS GSO EN 14683:2020 Scope

This document specifies construction, design, performance requirements and test methods for medical face masks intended to limit the transmission of infective agents from staff to patients during surgical procedures and other medical settings with similar requirements. A medical face mask with an appropriate microbial barrier can also be effective in reducing the emission of infective agents from the nose and mouth of an asymptomatic carrier or a patient with clinical symptoms. This European Standard is not applicable to masks intended exclusively for the personal protection of staff. NOTE 1 Standards for masks for use as respiratory personal protective equipment are available. NOTE 2 Annex A provides information for the users of medical face masks.

Best Sellers From Health Sector

GSO 2017:2023
 
Gulf Standard
Personal Care and Baby Wet Wipes
GSO 2241:2023
 
Gulf Standard
Cosmetic Products - Body Cleaners
GSO 1223:2023
 
Gulf Standard
Cosmetic Products-Deodorants
GSO 2302:2022
 
Gulf Standard
Cosmetic Products – Face Masks

Recently Published from Health Sector

GSO ISO 17069:2024
ISO 17069:2020 
Gulf Standard
Accessible design — Consideration and assistive products for accessible meeting
GSO ISO 11978:2024
ISO 11978:2017 
Gulf Standard
Ophthalmic optics — Contact lenses and contact lens care products — Labelling
GSO ISO 11608-6:2024
ISO 11608-6:2022 
Gulf Standard
Needle-based injection systems for medical use — Requirements and test methods — Part 6: On-body delivery systems
GSO ISO 16256:2024
ISO 16256:2021 
Gulf Standard
Clinical laboratory testing and in vitro diagnostic test systems — Broth micro-dilution reference method for testing the in vitro activity of antimicrobial agents against yeast fungi involved in infectious diseases